MedTrace Logo

Evaluation of a New Orange-Based Beverage Enriched With Polyphenols in Adult Humans

NCT01290250 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 210

Last updated 2013-03-15

No results posted yet for this study

Summary

The purpose of this study is to evaluate the effects of a new orange juice-based beverage enriched in fiber and selected phenolic compounds (mainly flavanones) on features of metabolic syndrome and cardiovascular disease risk factors related to inflammation and antioxidant defense system in overweight and obese adult humans. This study hypothesizes that consumption of an orange juice-based beverage enriched in fiber and selected phenolic compounds (mainly flavanones)would improve lipid levels and lipid metabolism,blood pressure and the Homeostatic Model Assessment (HOMA) index.

Conditions

Interventions

OTHER

Orange juice based beverage enriched in polyphenols

2 daily doses (250 ml each) during 3 months

Sponsors & Collaborators

  • The Coca-Cola Company

    lead INDUSTRY

Principal Investigators

  • Concepcion Aguilera, Phd · Universidad de Granada

  • Maria Dolores Mesa, PhD · Universidad de Granada

  • Angel Gil, PhD · Universidad de Granada

Study Design

Allocation
RANDOMIZED
Purpose
BASIC_SCIENCE
Masking
QUADRUPLE
Model
CROSSOVER

Eligibility

Min Age
30 Years
Max Age
65 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2010-02-28
Primary Completion
2011-01-31
Completion
2012-07-31

Countries

  • Spain

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01290250 on ClinicalTrials.gov